Highlights of the 34th EANM Annual Congress 2021, 2nd virtual edition: “FROM HAMBURG WITH LOVE” Nathalie L. AlbertIrene A. Burger Editorial 01 March 2022 Pages: 1435 - 1441
Challenges and possibilities for board exams in the Covid-19 era: experience from the Fellowship Committee of European Board of Nuclear Medicine Zehra OzcanIlona KulakieneAriane Boubaker Editorial 10 February 2022 Pages: 1442 - 1446
DNA damage and repair in peripheral blood mononuclear cells after internal ex vivo irradiation of patient blood with 131I S. SchumannH. ScherthanU. Eberlein Original Article Open access 13 November 2021 Pages: 1447 - 1455
Neural correlates of beneficial effects of young plasma treatment in aged mice: PET-SPM analyses and neuro-behavioural/molecular biological studies Kai ZhangHiroshi MizumaYasuyoshi Watanabe Original Article 03 December 2021 Pages: 1456 - 1469
64Cu-labeled daratumumab F(ab′)2 fragment enables early visualization of CD38-positive lymphoma Lei KangCuicui LiWeibo Cai Original Article 22 October 2021 Pages: 1470 - 1481
A metabolically stable PET tracer for imaging synaptic vesicle protein 2A: synthesis and preclinical characterization of [18F]SDM-16 Chao ZhengDaniel HoldenZhengxin Cai Original Article Open access 11 November 2021 Pages: 1482 - 1496
Longitudinal evaluation of five nasopharyngeal carcinoma animal models on the microPET/MR platform Jingjing ShiZhichao XuePek-Lan Khong Original Article 04 December 2021 Pages: 1497 - 1507
Deep learning–based denoising of low-dose SPECT myocardial perfusion images: quantitative assessment and clinical performance Narges Aghakhan OliaAlireza Kamali-AslHabib Zaidi Original Article Open access 15 November 2021 Pages: 1508 - 1522
Machine learning-based prediction of invisible intraprostatic prostate cancer lesions on 68 Ga-PSMA-11 PET/CT in patients with primary prostate cancer Zhilong YiSiqi HuYong Zhang Original Article 30 November 2021 Pages: 1523 - 1534
Machine learning in the differentiation of follicular lymphoma from diffuse large B-cell lymphoma with radiomic [18F]FDG PET/CT features F. Montes de JesusY. YinM. Nijland Original Article 01 December 2021 Pages: 1535 - 1543
Impact of COVID-19 infection on short-term outcome in patients referred to stress myocardial perfusion imaging Roberta AssanteAdriana D’AntonioWanda Acampa Original Article 13 November 2021 Pages: 1544 - 1552
Visualization of thermal damage using 68 Ga-FAPI-PET/CT after pulmonary vein isolation Jana KupusovicLukas KesslerJohannes Siebermair Original Article Open access 15 November 2021 Pages: 1553 - 1559
High-resolution pediatric age–specific 18F-FDG PET template: a pilot study in epileptogenic focus localization Teng ZhangYuting LiMei Tian Original Article Open access 08 November 2021 Pages: 1560 - 1573
Phase I/II clinical trial of high-dose [131I] meta-iodobenzylguanidine therapy for high-risk neuroblastoma preceding single myeloablative chemotherapy and haematopoietic stem cell transplantation Rie KurodaHiroshi WakabayashiSeigo Kinuya Original Article 27 November 2021 Pages: 1574 - 1583
Early molecular imaging response assessment based on determination of total viable tumor burden in [68Ga]Ga-PSMA-11 PET/CT independently predicts overall survival in [177Lu]Lu-PSMA-617 radioligand therapy Florian RosarFelix WennerSamer Ezziddin Original Article Open access 02 November 2021 Pages: 1584 - 1594
Efficacy and safety of 225Ac-DOTATATE targeted alpha therapy in metastatic paragangliomas: a pilot study Madhav Prasad YadavSanjana BallalChandrasekhar Bal Original Article 27 November 2021 Pages: 1595 - 1606
Can Q.Clear reconstruction be used to improve [68 Ga]Ga-DOTANOC PET/CT image quality in overweight NEN patients? Lucia ZanoniGiulia ArgaliaValentina Ambrosini Original Article 25 October 2021 Pages: 1607 - 1612
A prospective randomized, double-blind study to evaluate the diagnostic efficacy of 68Ga-NODAGA-LM3 and 68Ga-DOTA-LM3 in patients with well-differentiated neuroendocrine tumors: compared with 68Ga-DOTATATE Wenjia ZhuRu JiaLi Huo Original Article 07 December 2021 Pages: 1613 - 1622
The impact of the COVID-19 pandemic on oncological disease extent at FDG PET/CT staging: the ONCOVIPET study Carmelo CaldarellaFabrizio CocciolilloLucia Leccisotti Original Article 08 December 2021 Pages: 1623 - 1629
Risk of primary breast cancer in patients with differentiated thyroid cancer undergoing radioactive iodine therapy: a systematic review and meta-analysis Carmela NappiMichele KlainAlberto Cuocolo Original Article 25 November 2021 Pages: 1630 - 1639
Fluorescence grid analysis for the evaluation of piecemeal surgery in sinonasal inverted papilloma: a proof-of-concept study J VonkFJ VoskuilMJH Witjes Original Article Open access 05 November 2021 Pages: 1640 - 1649
Interleukin-6 as surrogate marker for imaging-based hypoxia dynamics in patients with head-and-neck cancers undergoing definitive chemoradiation—results from a prospective pilot trial Alexander RühleNicole WiedenmannNils H. Nicolay Original Article Open access 13 November 2021 Pages: 1650 - 1660
Incidence rate and factors associated with the development of secondary cancers after radioiodine therapy in differentiated thyroid cancer: a multicenter retrospective study Chae Moon HongJi-Yeon ShinJaetae Lee Original Article 13 November 2021 Pages: 1661 - 1670
[18F]AlF-NOTA-FAPI-04 PET/CT uptake in metastatic lesions on PET/CT imaging might distinguish different pathological types of lung cancer Yuchun WeiKai ChengShuanghu Yuan Original Article Open access 06 December 2021 Pages: 1671 - 1681
EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds M. WeberM. LamK. Herrmann Guidelines Open access 11 February 2022 Pages: 1682 - 1699
Dose–response relationship after yttrium-90-radioembolization with glass microspheres in patients with neuroendocrine tumor liver metastases Sander C. EbbersCaren van RoekelArthur J. A. T. Braat Original Article 07 December 2021 Pages: 1700 - 1710
68Ga-EMP-100 PET/CT—a novel ligand for visualizing c-MET expression in metastatic renal cell carcinoma—first in-human biodistribution and imaging results Lena M. MittlmeierAndrei TodicaPeter Bartenstein Original Article Open access 28 October 2021 Pages: 1711 - 1720
Hot needles can confirm accurate lesion sampling intraoperatively using [18F]PSMA-1007 PET/CT-guided biopsy in patients with suspected prostate cancer Daniela A. FerraroRiccardo LaudicellaIrene A. Burger Original Article Open access 02 November 2021 Pages: 1721 - 1730
Prospective analysis of clinically significant prostate cancer detection with [18F]DCFPyL PET/MRI compared to multiparametric MRI: a comparison with the histopathology in the radical prostatectomy specimen, the ProStaPET study Yves J. L. BodarBen G. J. C. ZwezerijnenDaniela E. Oprea-Lager Original Article Open access 02 November 2021 Pages: 1731 - 1742
The impact of drainage pathways on the detection of nodal metastases in prostate cancer: a phase II randomized comparison of intratumoral vs intraprostatic tracer injection for sentinel node detection Esther M. K. WitFlorian van BeurdenHenk G. van der Poel Original Article 08 November 2021 Pages: 1743 - 1753
177Lu-PSMA-617 versus docetaxel in chemotherapy-naïve metastatic castration-resistant prostate cancer: a randomized, controlled, phase 2 non-inferiority trial Swayamjeet SatapathyBhagwant Rai MittalShrawan Kumar Singh Original Article 29 November 2021 Pages: 1754 - 1764
Increased 68 Ga-FAPI-04 uptake in cutaneous plasmacytosis in a patient with IgG4-related disease Jianpeng CaoDengsai PengYue Chen Image of the Month 18 November 2021 Pages: 1765 - 1766
FAP-targeted radionuclide therapy with [177Lu]Lu-FAPI-46 in metastatic nasopharyngeal carcinoma Kaili FuYizhen PangHaojun Chen Image of the Month 08 December 2021 Pages: 1767 - 1769
[68Ga]Ga-FAPI PET/CT imaging of brown tumors in a patient with primary hyperparathyroidism Yizhen PangQihang ShangHaojun Chen Image of the Month 16 December 2021 Pages: 1770 - 1771